Form 4 for NVCR NovoCure Ltd
Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-02 · accession 0001645113-22-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-03 | 2022-08-02 | NVCR | Cordova Ashley | CFO | A - Grant | $70.20 | +7,122 | 73.3K | +11% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-02 | A | A | 7,122 | $70.20 | 73,261 | D | — | — | (F1) Represents restricted share units that are scheduled to vest in equal installments on each of August 2, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates. |